Skip to main content

Inhibition of the protein p38 reduces lung tumour growth




Press & Communications Section Head
Tel.+34 93 40 37255

Several media outlets have reported on a study led Angel Nebreda, ICREA researcher at the Institute for Research in Biomedicine (IRB Barcelona). In this work, his team has observed that p38 inhibition causes a dramatic reduction in the growth and aggressiveness of lung tumours.

Link to: La Vanguardia

Link to: ABC

Link to :El Confidencial

Link to: El Diario de León

Link to: La Voz de Cádiz


About IRB Barcelona

The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).